Patent · US Active

Antibody and protein formulations

US9592297B2 · kind B2 · utility

4Cited by
30References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2013
Grant dateMar 14, 2017
Priority date
Expiry dateJun 12, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are salt-free antibody and other protein formulations that are substantially isosmotic and of low viscosity. Also provided are methods for the treatment of diseases using the disclosed formulations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.